Extreme blood pressure after ephedrine: Should we rule out pheochromocytoma?: Ephedrine, selegiline

Erica D. Wittwer, Juraj Sprung, Wayne T. Nicholson

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This case discusses a pharmacokinetic interaction between selegiline and ephedrine-induced norepinephrine resulting in hypertension.

Original languageEnglish (US)
Title of host publicationA Case Approach to Perioperative Drug-Drug Interactions
PublisherSpringer New York
Pages585-588
Number of pages4
ISBN (Print)9781461474951, 9781461474944
DOIs
StatePublished - Sep 15 2015

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Extreme blood pressure after ephedrine: Should we rule out pheochromocytoma?: Ephedrine, selegiline'. Together they form a unique fingerprint.

  • Cite this

    Wittwer, E. D., Sprung, J., & Nicholson, W. T. (2015). Extreme blood pressure after ephedrine: Should we rule out pheochromocytoma?: Ephedrine, selegiline. In A Case Approach to Perioperative Drug-Drug Interactions (pp. 585-588). Springer New York. https://doi.org/10.1007/978-1-4614-7495-1_129